[HTML][HTML] Efficacy of ivermectin, chloroquine/hydroxychloroquine, and azithromycin in managing COVID-19: A systematic review of phase III clinical trials
Background: During the coronavirus disease (COVID)-19 pandemic several drugs were
used to manage the patients mainly those with a severe phenotype. Potential drugs were …
used to manage the patients mainly those with a severe phenotype. Potential drugs were …
Global trends in clinical trials of ivermectin for COVID-19—Part 2
M Yagisawa, PJ Foster, H Hanaki… - The Japanese Journal of …, 2024 - jstage.jst.go.jp
In March of 2021, when the third wave of the COVID-19 pandemic seemed to be under
control, the authors analyzed the circumstances that led to the global pandemic and …
control, the authors analyzed the circumstances that led to the global pandemic and …
イベルメクチンのCOVID-19 に対する臨床試験の世界的動向―その 2
八木澤守正， 花木秀明， 大村智 - The Japanese Journal of Antibiotics, 2024 - jstage.jst.go.jp
抄録 著者らが 2021 年 3 月に本誌に寄稿した総説では, 世界の 27 カ国から 91
件のイベルメクチンの COVID-19 に対する臨床試験が公的登録機関に登録されており, その中の …
件のイベルメクチンの COVID-19 に対する臨床試験が公的登録機関に登録されており, その中の …